Mary Hayes, Pharm D

Director, HPS Clinical Formulary & Medical Drug Strategies
Humana

Poster(s):

• (158) Understanding GIP/GLP-1 Treatment Dynamics: Switching and Re-initiation in Medicare Advantage Beneficiaries
  Wednesday, October 29, 2025